$TCNNF
Trulieve Cannabis Corp. Stock $tcnnf

$tcnnf Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000095017022009453 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$318.3M	$305.3M	$193.8M
YoY Change	64.25%	81.32%	101.78%
Cost Of Revenue	$140.2M	$172.9M	$58.56M
YoY Change	139.41%	255.78%	163.47%
Gross Profit	$178.2M	$132.4M	$135.3M
YoY Change	31.71%	10.46%	83.21%
Gross Profit Margin	55.96%	43.37%	69.79%
Selling, General & Admin	$106.4M	$117.0M	$57.27M
YoY Change	85.81%	124.98%	96.62%
% of Gross Profit	59.73%	88.34%	42.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.50M	$37.94M	$5.600M
YoY Change	176.79%	368.44%	75.0%
% of Gross Profit	8.7%	28.65%	4.14%
Operating Expenses	$149.5M	$145.3M	$62.70M
YoY Change	138.42%	159.85%	100.2%
Operating Profit	$28.66M	-$12.82M	$72.56M
YoY Change	-60.51%	-120.03%	70.69%
Interest Expense	$17.88M	-$13.89M	$7.899M
YoY Change	126.32%	275.3%	33.61%
% of Operating Profit	62.38%		10.89%
Other Income/Expense, Net	-$18.82M	$754.0K	-$7.936M
YoY Change	137.18%	-102.52%	683.42%
Pretax Income	$9.834M	-$31.32M	$64.63M
YoY Change	-84.78%	-203.03%	55.73%
Income Tax	$42.32M	$40.81M	$34.55M
% Of Pretax Income	430.3%		53.46%
Net Earnings	-$32.48M	-$72.13M	$30.08M
YoY Change	-207.99%	-2504.3%	27.42%
Net Earnings / Revenue	-10.2%	-23.62%	15.52%
Basic Earnings Per Share	-$0.17		$0.25
Diluted Earnings Per Share	-$0.17	-$382.6K	$0.24
COMMON SHARES
Basic Shares Outstanding	187.1M		119.9M
Diluted Shares Outstanding	187.1M		127.6M

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$267.2M	$230.6M	$162.5M
YoY Change	64.45%	57.22%	61.21%
Cash & Equivalents	$267.2M	$230.6M	$162.5M
Short-Term Investments
Other Short-Term Assets	$6.440M	$5.148M	$25.20M
YoY Change	-74.44%	73.98%	85.29%
Inventory	$236.4M	$212.2M	$103.9M
Prepaid Expenses	$10.68M	$10.33M
Receivables	$12.78M	$8.854M	$2.617M
Other Receivables	$10.17M	$1.530M	$0.00
Total Short-Term Assets	$593.3M	$524.4M	$290.4M
YoY Change	104.27%	100.58%	53.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$806.0M	$779.9M	$365.1M
YoY Change	120.74%	148.35%	67.19%
Goodwill	$789.9M	$765.4M	$70.21M
YoY Change	1025.09%	1039.33%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$34.04M	$18.31M	$11.24M
YoY Change	202.8%	143.28%	332.38%
Total Long-Term Assets	$2.933B	$2.886B	$611.7M
YoY Change	379.45%	426.41%	140.72%
TOTAL ASSETS
Total Short-Term Assets	$593.3M	$524.4M	$290.4M
Total Long-Term Assets	$2.933B	$2.886B	$611.7M
Total Assets	$3.526B	$3.411B	$902.1M
YoY Change	290.85%	321.21%	103.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.96M	$14.33M	$42.00M
YoY Change	-54.86%	54.95%	62.16%
Accrued Expenses	$86.77M	$9.840M	$3.300M
YoY Change	2529.36%	-30.7%	26.92%
Deferred Revenue	$6.514M	$7.168M	$6.780M
YoY Change	-3.92%	-0.14%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.874M	$17.23M	$6.300M
YoY Change	-70.25%	-3.75%	26.0%
Total Short-Term Liabilities	$237.8M	$168.9M	$101.1M
YoY Change	135.12%	121.93%	46.58%
LONG-TERM LIABILITIES
Long-Term Debt	$785.4M	$709.8M	$138.7M
YoY Change	466.24%	197.87%	91.57%
Other Long-Term Liabilities	$9.433M	$8.400M	$121.8M
YoY Change	-92.26%	114.56%	-12.61%
Total Long-Term Liabilities	$9.433M	$8.400M	$121.8M
YoY Change	-92.26%	114.56%	-42.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$237.8M	$168.9M	$101.1M
Total Long-Term Liabilities	$9.433M	$8.400M	$121.8M
Total Liabilities	$1.407B	$1.263B	$416.5M
YoY Change	237.73%	249.16%	45.73%
SHAREHOLDERS EQUITY
Retained Earnings	$105.7M	$137.7M	$149.8M
YoY Change	-29.39%	15.07%
Common Stock	$2.013B	$2.008B	$291.4M
YoY Change	590.69%	511.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.118B	$2.146B	$485.6M
YoY Change
Total Liabilities & Shareholders Equity	$3.526B	$3.411B	$897.5M
YoY Change	292.87%	321.21%	102.36%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$32.48M	-$72.13M	$30.08M
YoY Change	-207.99%	-2504.3%	27.42%
Depreciation, Depletion And Amortization	$15.50M	$37.94M	$5.600M
YoY Change	176.79%	368.44%	75.0%
Cash From Operating Activities	$45.15M	-$62.18M	$59.59M
YoY Change	-24.24%	-332.02%	149.13%
INVESTING ACTIVITIES
Capital Expenditures	$48.12M	-$97.23M	$48.39M
YoY Change	-0.56%	82.76%	75.3%
Acquisitions	$27.50M		-$91.00K
YoY Change	-30319.78%
Other Investing Activities	-$26.16M	$119.7M	-$270.0K
YoY Change	9589.63%	-490.61%	28.57%
Cash From Investing Activities	-$83.83M	$22.46M	-$53.36M
YoY Change	57.09%	-126.79%	91.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	72.25M	59.81M	9.508M
YoY Change	659.87%	476.75%	-26.23%
NET CHANGE
Cash From Operating Activities	45.15M	-62.18M	59.59M
Cash From Investing Activities	-83.83M	22.46M	-53.36M
Cash From Financing Activities	72.25M	59.81M	9.508M
Net Change In Cash	33.57M	20.09M	15.74M
YoY Change	113.3%	-143.04%	74.87%
FREE CASH FLOW
Cash From Operating Activities	$45.15M	-$62.18M	$59.59M
Capital Expenditures	$48.12M	-$97.23M	$48.39M
Free Cash Flow	-$2.971M	$35.04M	$11.20M
YoY Change	-126.52%	-56.2%	-404.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001754195
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-56248
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	TRULIEVE CANNABIS CORP.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-2231905
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6749 Ben Bostic Road
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Quincy
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32351
CY2022Q1	dei	City Area Code CityAreaCode	850
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	480-7955
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267226000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	230646000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	3013000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12782000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8854000
CY2022Q1	us-gaap	Inventory Net InventoryNet	236427000
CY2021Q4	us-gaap	Inventory Net InventoryNet	212188000
CY2022Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	634000
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1530000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	76182000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68189000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	593251000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	805999000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	524420000
CY2022Q1	tcnnf	Construction Finance Liabilities Current Portion ConstructionFinanceLiabilitiesCurrentPortion	1154000
CY2021Q4	tcnnf	Construction Finance Liabilities Current Portion ConstructionFinanceLiabilitiesCurrentPortion	991000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	779916000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	121972000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	125973000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	70225000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	66764000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1098278000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1117982000
CY2022Q1	us-gaap	Goodwill Goodwill	789900000
CY2021Q4	us-gaap	Goodwill Goodwill	765358000
CY2022Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12188000
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12147000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34041000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18312000
CY2022Q1	us-gaap	Assets Assets	3525854000
CY2021Q4	us-gaap	Assets Assets	3410872000
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	109810000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	94073000
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	77687000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	27610000
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6514000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7168000
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	9481000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10052000
CY2022Q1	tcnnf	Private Placement Notes Liability Current PrivatePlacementNotesLiabilityCurrent	1874000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10553000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9840000
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6905000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6185000
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	13826000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	13017000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	237804000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	168936000
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	3476000
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	6456000
CY2022Q1	tcnnf	Private Placement Notes Liabilities Net PrivatePlacementNotesLiabilitiesNet	537703000
CY2021Q4	tcnnf	Private Placement Notes Liabilities Net PrivatePlacementNotesLiabilitiesNet	462929000
CY2022Q1	tcnnf	Warrant Liabilities Noncurrent WarrantLiabilitiesNoncurrent	2075000
CY2021Q4	tcnnf	Warrant Liabilities Noncurrent WarrantLiabilitiesNoncurrent	2895000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128575000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	122130000
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	69167000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	65244000
CY2022Q1	tcnnf	Construction Finance Liabilities ConstructionFinanceLiabilities	175032000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18823000
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44558000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33546000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12709000
CY2021Q4	tcnnf	Construction Finance Liabilities ConstructionFinanceLiabilities	175198000
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	243395000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	251311000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9433000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8400000
CY2022Q1	us-gaap	Liabilities Liabilities	1406660000
CY2021Q4	us-gaap	Liabilities Liabilities	1263499000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184184142
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184184142
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	180504172
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	180504172
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2012564000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2008100000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	105746000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	137721000
CY2022Q1	us-gaap	Minority Interest MinorityInterest	884000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1552000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2119194000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2147373000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3525854000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3410872000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	318348000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193823000
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	140198000
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	58559000
CY2022Q1	us-gaap	Gross Profit GrossProfit	178150000
CY2021Q1	us-gaap	Gross Profit GrossProfit	135264000
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	72862000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29305000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5434000
CY2022Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	13780000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	149493000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	62701000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	28657000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	72563000
CY2022Q1	us-gaap	Interest Expense InterestExpense	17877000
CY2021Q1	us-gaap	Interest Expense InterestExpense	7899000
CY2022Q1	tcnnf	Gain Loss On Change In Fair Value Of Derivative Liabilities Warrants GainLossOnChangeInFairValueOfDerivativeLiabilitiesWarrants	820000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2681000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	915000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-37000
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7936000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	741000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9834000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	64627000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42316000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34549000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-32482000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30078000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-507000
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31975000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30078000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187054916
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119892507
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187054916
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127589096
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	447903000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	741000
CY2021Q1	tcnnf	Stock Issued During Period Value For Warrants Exercise StockIssuedDuringPeriodValueForWarrantsExercise	6861000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30078000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	485583000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2147373000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4564000
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108000
CY2022Q1	tcnnf	Stock Issued During Period Value For Warrants Exercise StockIssuedDuringPeriodValueForWarrantsExercise	22000
CY2022Q1	tcnnf	Tax Withholding Related To Net Share Settlement Of Equity Awards TaxWithholdingRelatedToNetShareSettlementOfEquityAwards	230000
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	50000
CY2022Q1	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	111000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-32482000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2119194000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-32482000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	30078000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29305000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5434000
CY2022Q1	tcnnf	Depreciation Included In Cost Of Goods Sold DepreciationIncludedInCostOfGoodsSold	10692000
CY2021Q1	tcnnf	Depreciation Included In Cost Of Goods Sold DepreciationIncludedInCostOfGoodsSold	3667000
CY2022Q1	tcnnf	Non Cash Interest Income Expense NonCashInterestIncomeExpense	-1232000
CY2021Q1	tcnnf	Non Cash Interest Income Expense NonCashInterestIncomeExpense	41000
CY2022Q1	tcnnf	Non Cash Interest Income NonCashInterestIncome	163000
CY2022Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	13780000
CY2022Q1	tcnnf	Gain Loss On Settlement Of Held For Sale Assets Net GainLossOnSettlementOfHeldForSaleAssetsNet	-1862000
CY2022Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-819000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2892000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1573000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4564000
CY2022Q1	tcnnf	Accretion Of Construction Finance Liability AccretionOfConstructionFinanceLiability	293000
CY2021Q1	tcnnf	Accretion Of Construction Finance Liability AccretionOfConstructionFinanceLiability	711000
CY2022Q1	tcnnf	Gain Loss On Change In Fair Value Of Derivative Liabilities Warrants GainLossOnChangeInFairValueOfDerivativeLiabilitiesWarrants	820000
CY2022Q1	tcnnf	Change In Legal Contingencies ChangeInLegalContingencies	-1248000
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	42000
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1487000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21957000
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5598000
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3970000
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2309000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8094000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1673000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16216000
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7298000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	22093000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	595000
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	42210000
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	36540000
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2106000
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-943000
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-654000
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-399000
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2057000
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1016000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45147000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	59591000
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48118000
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48387000
CY2022Q1	tcnnf	Payments For Purchases Of Property And Equipment Related To Construction Finance Liability PaymentsForPurchasesOfPropertyAndEquipmentRelatedToConstructionFinanceLiability	7334000
CY2021Q1	tcnnf	Payments For Purchases Of Property And Equipment Related To Construction Finance Liability PaymentsForPurchasesOfPropertyAndEquipmentRelatedToConstructionFinanceLiability	3687000
CY2022Q1	tcnnf	Repayment Of Capitalized Interest RepaymentOfCapitalizedInterest	1487000
CY2021Q1	tcnnf	Repayment Of Capitalized Interest RepaymentOfCapitalizedInterest	365000
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27500000
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-91000
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	2214000
CY2021Q1	us-gaap	Payments For Software PaymentsForSoftware	1014000
CY2022Q1	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	1604000
CY2022Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	203000
CY2022Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1018000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-83828000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53362000
CY2022Q1	tcnnf	Proceeds From Debt Financings Net Of Discounts And Accrued Interest ProceedsFromDebtFinancingsNetOfDiscountsAndAccruedInterest	76420000
CY2021Q1	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	3687000
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	22000
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6861000
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	108000
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2285000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1421000
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1028000
CY2022Q1	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	297000
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	19000
CY2021Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12000
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	230000
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	50000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72248000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9508000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	33567000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15737000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	233659000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	146713000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267226000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	162450000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	6949000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	540000
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	46000
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	10852000
CY2021Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	10697000
CY2022Q1	tcnnf	Purchase Of Property And Equipment Financed With Accounts Payable PurchaseOfPropertyAndEquipmentFinancedWithAccountsPayable	10985000
CY2021Q1	tcnnf	Purchase Of Property And Equipment Financed With Accounts Payable PurchaseOfPropertyAndEquipmentFinancedWithAccountsPayable	13155000
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="notes_to_financial_statements" style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">NOTE </span><span id="footnotes"/><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1. NATURE OF BUSINESS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Trulieve Cannabis Corp. together with its subsidiaries (“Trulieve” or the “Company”) was incorporated in British Columbia, Canada. Trulieve is a vertically integrated cannabis company which, as of March 31, 2022, held licenses to operate in Florida, California, Connecticut, Pennsylvania, Massachusetts, West Virginia, Arizona, Colorado, Maryland, and Nevada, to cultivate, produce, and sell medicinal-use cannabis products, and with respect to Arizona, California, Colorado, Nevada, and Massachusetts, adult-use cannabis products, and have received notice of intent to award a license in Georgia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p id="notes_to_the_fs" style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In addition to the States listed above, the Company also conducts activities in other markets. In these markets, the Company has either applied for licenses, plans on applying for licenses, or partners with other entities, but does not currently directly own any cultivation, production or retail licenses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In July 2018, Trulieve, Inc. entered into a non-binding letter agreement (“Letter Agreement”) with Schyan Exploration Inc. (“Schyan”) whereby Trulieve, Inc. and Schyan have agreed to merge their respective businesses resulting in a reverse takeover of Schyan by Trulieve, Inc. and change the business of Schyan from a mining issuer to a marijuana issuer (the “Transaction”). The Transaction was completed in August 2018 and Schyan changed its name to Trulieve Cannabis Corp.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s principal address is located in Quincy, Florida. The Company’s registered office is located in British Columbia. Our operations are substantially located in Florida and to a lesser extent Arizona and Pennsylvania.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is listed on the Canadian Securities Exchange (the “CSE”) and began trading on September 25, 2018, under the ticker symbol “TRUL” and trades on the OTCQX market under the symbol “TCNNF”.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">NOTE </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2. BASIS OF PRESENTATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Principles of consolidation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements include the financial position and operations of Trulieve Cannabis Corp. and its subsidiaries. The condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and include the assets, liabilities, revenue and expenses of all wholly-owned subsidiaries and variable interest entities for which we have determined that we are the primary beneficiary. Outside shareholders' interests in subsidiaries are shown on the condensed consolidated financial statements as non-controlling interests. Material intercompany balances and transactions are eliminated in consolidation. In our opinion, the condensed consolidated financial statements include all adjustments of a normal recurring nature necessary to present fairly our financial position as of March 31, 2022, and the results of our operations and cash flows for the three months ended March 31, 2022 and March 31, 2021. The results of our operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the full 2022 fiscal year.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">A variable interest entity (“VIE”) is a legal entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support, is structured such that equity investors lack the ability to make significant decisions relating to the entity’s operations through voting rights, or do not substantively participate in the gains and losses of the entity. Upon inception of a contractual agreement, the Company performs an assessment to determine whether the arrangement contains a variable interest in a legal entity and whether that legal entity is a VIE. The primary beneficiary has both the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE entity that could potentially be significant to the VIE. Where the Company concludes it is the primary beneficiary of a VIE, the Company consolidates the accounts of that VIE. When the Company is not the primary beneficiary, the VIE is accounted for using the equity method and is included in equity method investments on the consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company regularly reviews and reconsiders previous conclusions regarding whether it is the primary beneficiary of a VIE in accordance with FASB ASC 810. The Company also reviews and reconsiders previous conclusions regarding whether the Company holds a variable interest in a potential VIE, the status of an entity as a VIE, and whether the Company is required to consolidate such a VIE in the consolidated financial statements when a change occurs.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2021, as reported in the 2021 Annual Report on Form 10-K.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Basis of Measurement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">These condensed consolidated financial statements have been prepared on the going concern basis, under the historical cost convention, except for certain financial instruments that are measured at fair value as described herein.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Functional Currency</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The functional currency of the Company and its subsidiaries, as determined by management, is the United States (“U.S.”) dollar. These condensed consolidated financial statements are presented in U.S. dollars.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to the condensed consolidated financial statements of prior periods and the accompanying notes to conform to the current period presentation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6787000
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to the condensed consolidated financial statements of prior periods and the accompanying notes to conform to the current period presentation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Critical accounting estimates and judgments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the condensed consolidated financial statements with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates in our condensed consolidated financial statements, include, but are not limited to, accounting for acquisitions and business combinations; initial valuation and subsequent impairment testing of goodwill, other intangible assets and long-lived assets; leases; fair value of financial instruments, income taxes; inventory; share-based payment arrangements, and commitment and contingencies. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	3000000.0
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	0
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	18958000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14330000
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	27245000
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	24728000
CY2022Q1	tcnnf	Accrued Property And Equipment AccruedPropertyAndEquipment	10985000
CY2021Q4	tcnnf	Accrued Property And Equipment AccruedPropertyAndEquipment	6507000
CY2021Q4	tcnnf	Accrued Property And Equipment Related Party AccruedPropertyAndEquipmentRelatedParty	11353000
CY2022Q1	tcnnf	Accrued Inventory Current AccruedInventoryCurrent	11039000
CY2021Q4	tcnnf	Accrued Inventory Current AccruedInventoryCurrent	8373000
CY2022Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3449000
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	6620000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	17673000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68189000
CY2022Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	317000
CY2021Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	990000
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5508000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5352000
CY2022Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	14636000
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	9033000
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	109810000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	94073000
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	6073000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	10175000
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10677000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10325000
CY2022Q1	tcnnf	Prepaid Payroll Current PrepaidPayrollCurrent	12809000
CY2022Q1	tcnnf	Tenant Improvement Receivables TenantImprovementReceivables	9539000
CY2021Q4	tcnnf	Tenant Improvement Receivables TenantImprovementReceivables	16853000
CY2022Q1	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	9460000
CY2021Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	8719000
CY2022Q1	us-gaap	Security Deposit SecurityDeposit	11185000
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	16969000
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	9999000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	6440000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5148000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	76182000
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6200000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6700000
CY2022Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	9500000
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	8700000
CY2022Q1	tcnnf	Proceeds From Non Productive Assets ProceedsFromNonProductiveAssets	700000
CY2022Q1	us-gaap	Proceeds From Sale Of Land Held For Use ProceedsFromSaleOfLandHeldForUse	200000
CY2022Q1	tcnnf	Gain Loss On Divestment And Sale Of Non Operating Assets GainLossOnDivestmentAndSaleOfNonOperatingAssets	-2600000
CY2021Q4	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	18400000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12782000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8854000
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	13633000
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	9363000
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	851000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	509000
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	12935000
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	13801000
CY2022Q1	tcnnf	Discount On Notes Receivable DiscountOnNotesReceivable	113000
CY2021Q4	tcnnf	Discount On Notes Receivable DiscountOnNotesReceivable	124000
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	12822000
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	13677000
CY2022Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	634000
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1530000
CY2022Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12188000
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12147000
CY2021Q3	us-gaap	Notes Receivable Net NotesReceivableNet	0
CY2022Q1	tcnnf	Notes Receivable Expected Principal Payments Remainder Of Fiscal Year NotesReceivableExpectedPrincipalPaymentsRemainderOfFiscalYear	454000
CY2022Q1	tcnnf	Notes Receivable Expected Principal Payments In Next Twelve Months NotesReceivableExpectedPrincipalPaymentsInNextTwelveMonths	728000
CY2022Q1	tcnnf	Notes Receivable Expected Principal Payments Year Two NotesReceivableExpectedPrincipalPaymentsYearTwo	5060000
CY2022Q1	tcnnf	Notes Receivable Expected Principal Payments Year Three NotesReceivableExpectedPrincipalPaymentsYearThree	6693000
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	12935000
CY2022Q1	tcnnf	Discount On Notes Receivable DiscountOnNotesReceivable	113000
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	12822000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1456646
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	75724000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	71605000
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	99671000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	94249000
CY2022Q1	us-gaap	Inventory Net InventoryNet	236427000
CY2021Q4	us-gaap	Inventory Net InventoryNet	212188000
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	883013000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	843527000
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77014000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63611000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	805999000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	779916000
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1500000
CY2021Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000
CY2022Q1	us-gaap	Depreciation Depreciation	15500000
CY2021Q1	us-gaap	Depreciation Depreciation	5600000
CY2022Q1	tcnnf	Loss On Disposal Of Long Lived Assets LossOnDisposalOfLongLivedAssets	3000000.0
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	300000
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1153074000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	54796000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1098278000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1150860000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32878000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1117982000
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21900000
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y1M2D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M9D
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	64964000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	82161000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	80419000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	78392000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	76894000
CY2022Q1	tcnnf	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	715448000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1098278000
CY2021Q4	us-gaap	Goodwill Goodwill	765358000
CY2022Q1	us-gaap	Goodwill Goodwill	789900000
CY2022Q1	us-gaap	Notes Payable NotesPayable	13013000
CY2021Q4	us-gaap	Notes Payable NotesPayable	16600000
CY2022Q1	tcnnf	Notes Payable Debt Discount Current NotesPayableDebtDiscountCurrent	56000
CY2021Q4	tcnnf	Notes Payable Debt Discount Current NotesPayableDebtDiscountCurrent	92000
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	9481000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10052000
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	3476000
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	6456000
CY2022Q1	tcnnf	Notes Payable Maturity Remainder Of Fiscal Year NotesPayableMaturityRemainderOfFiscalYear	6697000
CY2022Q1	tcnnf	Notes Payable Maturing In Next Twelve Months NotesPayableMaturingInNextTwelveMonths	4711000
CY2022Q1	tcnnf	Notes Payable Maturing In Year Two NotesPayableMaturingInYearTwo	657000
CY2022Q1	tcnnf	Construction Finance Liabilities ConstructionFinanceLiabilities	175032000
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9566000
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5613000
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1424000
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1579000
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	802000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1421000
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1028000
CY2022Q1	tcnnf	Notes Payable Maturing In Year Three NotesPayableMaturingInYearThree	14000
CY2022Q1	tcnnf	Notes Payable Maturing In Year Four NotesPayableMaturingInYearFour	4000
CY2022Q1	tcnnf	Notes Payable Maturing Thereafter NotesPayableMaturingThereafter	930000
CY2022Q1	us-gaap	Notes Payable NotesPayable	13013000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1874000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	130000000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	425000000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	556874000
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	17297000
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1874000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	537703000
CY2022Q1	tcnnf	Gain Loss On Disposal Of Operating Right Of Use Assets GainLossOnDisposalOfOperatingRightOfUseAssets	-10500000
CY2022Q1	tcnnf	Finance Lease Cost FinanceLeaseCost	4094000
CY2021Q1	tcnnf	Finance Lease Cost FinanceLeaseCost	2349000
CY2022Q1	us-gaap	Lease Cost LeaseCost	12220000
CY2021Q1	us-gaap	Lease Cost LeaseCost	4317000
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5387000
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6301000
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	5084000
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0958
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0969
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0865
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0868
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y11M4D
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	76072000
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M28D
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	17371000
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	9852000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22465000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	15930000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	22145000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	12160000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	21792000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	11747000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21259000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	11325000
CY2022Q1	tcnnf	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	118546000
CY2022Q1	tcnnf	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	47049000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	223578000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	108063000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	84450000
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	31991000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	139128000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10553000
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6905000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128575000
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	69167000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due Remainder Of Fiscal Year ConstructionFinanceLiabilityPaymentsDueRemainderOfFiscalYear	17068000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due Next Twelve Months ConstructionFinanceLiabilityPaymentsDueNextTwelveMonths	23406000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due Year Two ConstructionFinanceLiabilityPaymentsDueYearTwo	23737000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due Year Three ConstructionFinanceLiabilityPaymentsDueYearThree	24176000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due Year Four ConstructionFinanceLiabilityPaymentsDueYearFour	24595000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due Year After Year Four ConstructionFinanceLiabilityPaymentsDueYearAfterYearFour	427860000
CY2022Q1	tcnnf	Construction Finance Liability Payments Due ConstructionFinanceLiabilityPaymentsDue	540842000
CY2022Q1	tcnnf	Construction Finance Liabilities Undiscounted Excess Amount ConstructionFinanceLiabilitiesUndiscountedExcessAmount	364656000
CY2022Q1	tcnnf	Construction Finance Liabilities Present Value Of Minimum Payments ConstructionFinanceLiabilitiesPresentValueOfMinimumPayments	176186000
CY2022Q1	tcnnf	Construction Finance Liabilities Current Portion ConstructionFinanceLiabilitiesCurrentPortion	1154000
CY2021Q1	tcnnf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value At Grant Date ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueAtGrantDate	11.20
CY2021Q1	us-gaap	Share Price SharePrice	33.42
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	33.42
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.5181
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.5287
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4988
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0120
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0179
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0011
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2200000
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2973895
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.61
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M3D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	864051
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	21.56
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	88278
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.32
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	121127
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	55.93
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3628541
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.62
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M23D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1569874
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.21
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M12D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2840
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1129779
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.72
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19900
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	326867
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	33.42
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.59
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y18D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28910
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	554459
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.70
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M2D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	33800
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12700000
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y10M28D
CY2018Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8784872
CY2018Q4	tcnnf	Class Of Warrant Or Right Vesting ClassOfWarrantOrRightVesting	0
CY2018	tcnnf	Class Of Warrant Or Right Exercisable Term ClassOfWarrantOrRightExercisableTerm	P3Y
CY2022Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	(i) the warrants may not be exercised for 18 months following the Issue Date; (ii) 50% of the warrants may be exercised between months 19-24 following the Issue Date; and (iii) the remaining 50% of the warrants may be exercised at any time thereafter until expiration.
CY2018	tcnnf	Class Of Warrant Or Right May Not Be Exercised Term ClassOfWarrantOrRightMayNotBeExercisedTerm	P18M
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-32482000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30078000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-507000
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31975000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30078000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187054916
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119892507
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	7696589
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187054916
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127589096
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184000000
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184000000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193823000
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9834000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	64627000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42316000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34549000
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	4.30
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.53
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	44900000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	44900000
CY2022Q1	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	1600000
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	0
CY2022Q1	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	0
CY2021Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	400000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	148400000
CY2022Q1	tcnnf	Expenses Recognized For Related Party Leases ExpensesRecognizedForRelatedPartyLeases	100000
CY2021Q1	tcnnf	Expenses Recognized For Related Party Leases ExpensesRecognizedForRelatedPartyLeases	100000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	318348000
CY2021Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Equity Level2 To Level1 Transfers Amount FairValueEquityLevel2ToLevel1TransfersAmount	0
CY2021Q4	us-gaap	Fair Value Equity Level2 To Level1 Transfers Amount FairValueEquityLevel2ToLevel1TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Equity Level1 To Level2 Transfers Amount FairValueEquityLevel1ToLevel2TransfersAmount	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2022Q1	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2021Q4	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2021Q4	us-gaap	Fair Value Equity Level1 To Level2 Transfers Amount FairValueEquityLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2021Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2021Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0

Files In Submission

Name	View Source	Status
0000950170-22-009453-index-headers.html	Edgar Link	pending
0000950170-22-009453-index.html	Edgar Link	pending
0000950170-22-009453.txt	Edgar Link	pending
0000950170-22-009453-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img6205653_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tcnnf-20220331.htm	Edgar Link	pending
tcnnf-20220331.xsd	Edgar Link	pending
tcnnf-20220331_cal.xml	Edgar Link	unprocessable
tcnnf-20220331_def.xml	Edgar Link	unprocessable
tcnnf-20220331_htm.xml	Edgar Link	completed
tcnnf-20220331_lab.xml	Edgar Link	unprocessable
tcnnf-20220331_pre.xml	Edgar Link	unprocessable
tcnnf-ex31_1.htm	Edgar Link	pending
tcnnf-ex31_2.htm	Edgar Link	pending
tcnnf-ex32_1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TCNNF
Trulieve Cannabis Corp. Stock $tcnnf

2022 Q1 Form 10-Q Financial Statement

#000095017022009453 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TCNNF Trulieve Cannabis Corp. Stock $tcnnf

2022 Q1 Form 10-Q Financial Statement

#000095017022009453 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TCNNF
Trulieve Cannabis Corp. Stock $tcnnf